Form 4: HealthStream SVP Scott Fenstermacher Reports Stock Transactions
SEC Form 4 Filing
Senior Vice President Scott Fenstermacher of HealthStream Inc. reports the vesting of restricted share units and subsequent tax withholding.
Summary
- On February 27, 2025, Scott Fenstermacher, a Senior Vice President at HealthStream Inc., reported transactions involving HealthStream's common stock.
- 2,000 shares were acquired upon the vesting of restricted share units (RSUs) at a price of $0.
- 659 shares were withheld for payment of tax liability at a price of $32.37.
- Following these transactions, Fenstermacher directly owns 14,327 shares of HealthStream common stock and 6,500 restricted share units.
- Additionally, 3,606 restricted share units were acquired, vesting in installments through February 27, 2030, contingent upon continued service and performance criteria.
Sentiment
Score: 6
Explanation: The document reflects routine insider transactions related to stock-based compensation. It is neutral in tone and does not indicate any significant positive or negative developments for the company.
Positives
- The vesting of restricted share units indicates that performance criteria for the period January 1, 2024 through December 31, 2024 were achieved, leading to the vesting of 20% of the awards on February 23, 2025.
- The acquisition of additional restricted share units suggests continued confidence in the company's future performance.
Risks
- The vesting of restricted share units is contingent upon continued service and the achievement of performance criteria, which introduces uncertainty regarding future vesting.
- The document does not provide specific details about the performance criteria, making it difficult to assess the likelihood of future vesting.
Future Outlook
The vesting schedule for the restricted share units extends through February 27, 2030, contingent upon continued service and the achievement of performance criteria established annually by the Compensation Committee.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the healthcare technology industry to align management's interests with those of shareholders.
- Companies like Cerner (now Oracle Health) and Allscripts also utilize restricted stock units and stock options as part of their compensation packages.
- The vesting schedules and performance criteria associated with these awards vary across companies, but typically include metrics related to revenue growth, profitability, and strategic goals.
Stakeholder Impact
- Shareholders may view the vesting of restricted share units as a positive sign, indicating that management is incentivized to improve company performance.
- Employees who also hold restricted share units may be encouraged by the vesting of Fenstermacher's units, as it suggests that performance goals are achievable.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | 15% of RSUs vest for the period January 1, 2023 through December 31, 2023. |
| 02/27/2025 | Date of transaction: vesting of 2,000 RSUs and withholding of 659 shares for tax liability. |
| 02/23/2025 | 20% of RSUs vest for the period January 1, 2024 through December 31, 2024. |
| 02/23/2026 | 20% of RSUs vest for the period January 1, 2025 through December 31, 2025. |
| 02/23/2027 | 20% of RSUs vest for the period January 1, 2026 through December 31, 2026. |
| 02/23/2028 | 25% of RSUs vest for the period January 1, 2027 through December 31, 2027. |
| 02/27/2026 | 15% of RSUs vest for the period January 1, 2025 through December 31, 2025. |
| 02/27/2027 | 20% of RSUs vest for the period January 1, 2026 through December 31, 2026. |
| 02/27/2028 | 20% of RSUs vest for the period January 1, 2027 through December 31, 2027. |
| 02/27/2029 | 20% of RSUs vest for the period January 1, 2028 through December 31, 2028. |
| 02/27/2030 | 25% of RSUs vest for the period January 1, 2029 through December 31, 2029. |
| 02/28/2025 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.